MAP Kinases are effector kinases that orchestrate diverse but coordinated responses to extracellular signals. In addition they play an essential role in malignant transformation in response to virtually all oncogenes. Upon activation, MAP Kinases move to sites of action where they phosphorylate proteins, thus altering their activity and bringing about the Changes in growth, death, differentiation and function appropriate for the particular cell-agonist interaction. Although the importance of MAP Kinases in cellular physiology is well-established, few functionally significant substrates have been unambiguously identified. To address this problem, we propose three major Specific Aims: I. Engineering Mutant MAP Kinase. We propose to engineer MAP kinase mutants capable of utilizing orthogonal ATP analogs as tools to identify the primary substrates of MAP kinase. II. CENP-E ani Other Mitotic Substrates of MAP Kinase. We will begin by analyzing the primary substrates for MAP Kinase in mitotic Chromosomes, since we have found that a portion of the active MAP kinase in mitosis is in kinetochores, and we have identified the microtubule motor protein CENP-E as a candidate substrate. We also will analyze the mechanism by which MAP Kinases stably associate with these structures, mapping the interaction domains on kinase and substrate. The functional importance of these phosphorylations will be assessed where appropriate. III. Activation pathway for MAP Kinase in G2 and M. We will ask what the signaling pathway is that activates MAP Kinase in mitosis. Active MAP Kinase in other times and places. In addition to the three major Aims, we propose preliminary studies to extend this investigational paradigm to other sites of localization of active MAP Kinase, in particular the nucleus during interphase.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA040042-14
Application #
6231041
Study Section
Special Emphasis Panel (ZCA1-GRB-S (M1))
Project Start
1985-09-30
Project End
2004-04-30
Budget Start
Budget End
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Walters, Dustin M; Lindberg, James M; Adair, Sara J et al. (2013) Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. Neoplasia 15:143-55
Guerrero, Michael S; Parsons, J Thomas; Bouton, Amy H (2012) Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. Genes Cancer 3:371-81
Owen, Katherine A; Abshire, Michelle Y; Tilghman, Robert W et al. (2011) FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PLoS One 6:e23123
Ohama, Takashi; Brautigan, David L (2010) Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem 285:8711-8
Hall, Emily H; Balsbaugh, Jeremy L; Rose, Kristie L et al. (2010) Comprehensive analysis of phosphorylation sites in Tensin1 reveals regulation by p38MAPK. Mol Cell Proteomics 9:2853-63
Slack-Davis, Jill K; Hershey, E Daniel; Theodorescu, Dan et al. (2009) Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Ther 8:2470-7
Hall, Emily H; Daugherty, Abbi E; Choi, Colin K et al. (2009) Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion. J Biol Chem 284:34713-22
Molhoek, Kerrington R; McSkimming, Chantel C; Olson, Walter C et al. (2009) Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2. Cancer Immunol Immunother 58:867-76
Tilghman, Robert W; Parsons, J Thomas (2008) Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol 18:45-52
Vomastek, Tomas; Iwanicki, Marcin P; Burack, W Richard et al. (2008) Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Mol Cell Biol 28:6954-66

Showing the most recent 10 out of 222 publications